The European Union is currently undertaking a significant revision of its pharmaceutical legislation with the overarching goals of ensuring timely and equitable access to safe, effective, and affordable medicines for all patients across the EU, enhancing the security of the supply of medicines, maintaining an environment conducive to pharmaceutical research and development, improving the environmental sustainability of medicines, and addressing antimicrobial resistance.
